Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters











Language
Publication year range
1.
J Biomed Biotechnol ; 2012: 758513, 2012.
Article in English | MEDLINE | ID: mdl-23118516

ABSTRACT

Leptospirosis is considered a neglected infectious disease of human and veterinary concern. Although extensive investigations on host-pathogen interactions have been pursued by several research groups, mechanisms of infection, invasion and persistence of pathogenic Leptospira spp. remain to be elucidated. We have reported the ability of leptospires to bind human plasminogen (PLG) and to generate enzimatically active plasmin (PLA) on the bacteria surface. PLA-coated Leptospira can degrade immobilized ECM molecules, an activity with implications in host tissue penetration. Moreover, we have identified and characterized several proteins that may act as PLG-binding receptors, each of them competent to generate active plasmin. The PLA activity associated to the outer surface of Leptospira could hamper the host immune attack by conferring the bacteria some benefit during infection. The PLA-coated leptospires obstruct complement C3b and IgG depositions on the bacterial surface, most probably through degradation. The decrease of leptospiral opsonization might be an important aspect of the immune evasion strategy. We believe that the presence of PLA on the leptospiral surface may (i) facilitate host tissue penetration, (ii) help the bacteria to evade the immune system and, as a consequence, (iii) permit Leptospira to reach secondary sites of infection.


Subject(s)
Bacterial Proteins/metabolism , Fibrinolysin/metabolism , Host-Pathogen Interactions , Leptospira/cytology , Leptospira/metabolism , Plasminogen/metabolism , Aminocaproates/metabolism , Cell Extracts , Complement C3b/metabolism , Electrophoresis, Gel, Two-Dimensional , Enzyme Activation , Fibronectins/metabolism , Humans , Immobilized Proteins/metabolism , Immune Sera/immunology , Immunoglobulin G/metabolism , Laminin/metabolism , Leptospirosis/blood , Leptospirosis/immunology , Leptospirosis/microbiology , Microbial Viability , Microscopy, Fluorescence , Protein Binding , Proteolysis , Proteomics , Recombinant Proteins/metabolism , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Substrate Specificity
2.
Braz J Med Biol Res ; 33(9): 1015-21, 2000 Sep.
Article in English | MEDLINE | ID: mdl-10973131

ABSTRACT

The interaction of plasminogen, tissue plasminogen activator (t-PA) and urokinase with a clinical strain of Helicobacter pylori was studied. Plasminogen bound to the surface of H. pylori cells in a concentration-dependent manner and could be activated to the enzymatic form, plasmin, by t-PA. Affinity chromatography assays revealed a plasminogen-binding protein of 58.9 kDa in water extracts of surface proteins. Surface-associated plasmin activity, detected with the chromogenic substrate CBS 00.65, was observed only when plasminogen and an exogenous activator were added to the cell suspension. The two physiologic plasminogen activators, t-PA and urokinase, were also shown to bind to and remain active on the surface of bacterial cells. epsilon-Aminocaproic acid caused partial inhibition of t-PA binding, suggesting that the kringle 2 structure of this activator is involved in the interaction with surface receptors. The activation of plasminogen by t-PA, but not urokinase, strongly depended on the presence of cells and a 25-fold enhancer effect on the initial velocity of activation by t-PA compared to urokinase was established. Furthermore, a relationship between cell concentration and the initial velocity of activation was demonstrated. These findings support the concept that plasminogen activation by t-PA on the bacterial surface is a surface-dependent reaction which offers catalytic advantages.


Subject(s)
Fibrinolytic Agents/metabolism , Helicobacter pylori/metabolism , Plasminogen Activators/metabolism , Tissue Plasminogen Activator/metabolism , Aminocaproates/metabolism , Chromatography , Electrophoresis, Polyacrylamide Gel , Humans , Indicators and Reagents , Receptors, Cell Surface/metabolism , Urokinase-Type Plasminogen Activator/metabolism
3.
Rev. bras. pesqui. méd. biol ; Braz. j. med. biol. res;33(9): 1015-21, Sept. 2000.
Article in English | LILACS | ID: lil-267977

ABSTRACT

The interaction of plasminogen, tissue plasminogen activator (t-PA) and urokinase with a clinical strain of Helicobacter pylori was studied. Plasminogen bound to the surface of H. pylori cells in a concentration-dependent manner and could be activated to the enzymatic form, plasmin, by t-PA. Affinity chromatography assays revealed a plasminogen-binding protein of 58.9 kDa in water extracts of surface proteins. Surface-associated plasmin activity, detected with the chromogenic substrate CBS 00.65, was observed only when plasminogen and an exogenous activator were added to the cell suspension. The two physiologic plasminogen activators, t-PA and urokinase, were also shown to bind to and remain active on the surface of bacterial cells. epsilon-Aminocaproic acid caused partial inhibition of t-PA binding, suggesting that the kringle 2 structure of this activator is involved in the interaction with surface receptors. The activation of plasminogen by t-PA, but not urokinase, strongly depended on the presence of cells and a 25-fold enhancer effect on the initial velocity of activation by t-PA compared to urokinase was established. Furthermore, a relationship between cell concentration and the initial velocity of activation was demonstrated. These findings support the concept that plasminogen activation by t-PA on the bacterial surface is a surface-dependent reaction which offers catalytic advantages


Subject(s)
Humans , Fibrinolytic Agents/metabolism , Helicobacter pylori/metabolism , Plasminogen Activators/metabolism , Tissue Plasminogen Activator/metabolism , Aminocaproates/metabolism , Chromatography , Electrophoresis, Polyacrylamide Gel , Helicobacter pylori/isolation & purification , Indicators and Reagents , Receptors, Cell Surface/metabolism , Urokinase-Type Plasminogen Activator/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL